Federated Investors Inc. PA grew its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 258.6% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 5,486 shares of the medical instruments supplier’s stock after purchasing an additional 3,956 shares during the quarter. Federated Investors Inc. PA’s holdings in DENTSPLY SIRONA were worth $356,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in the company. Dupont Capital Management Corp purchased a new stake in DENTSPLY SIRONA in the second quarter worth $116,000. Korea Investment CORP lifted its stake in DENTSPLY SIRONA by 139.9% in the second quarter. Korea Investment CORP now owns 2,145 shares of the medical instruments supplier’s stock worth $139,000 after acquiring an additional 1,251 shares during the period. Penserra Capital Management LLC lifted its stake in DENTSPLY SIRONA by 9.5% in the first quarter. Penserra Capital Management LLC now owns 2,760 shares of the medical instruments supplier’s stock worth $172,000 after acquiring an additional 240 shares during the period. Ballentine Partners LLC purchased a new stake in DENTSPLY SIRONA in the second quarter worth $203,000. Finally, Bridgewater Wealth & Financial Management LLC purchased a new stake in DENTSPLY SIRONA in the second quarter worth $214,000. 93.87% of the stock is owned by hedge funds and other institutional investors.

A number of analysts recently commented on XRAY shares. BidaskClub lowered DENTSPLY SIRONA from a “sell” rating to a “strong sell” rating in a research note on Wednesday, August 16th. Zacks Investment Research lowered DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research note on Monday, August 14th. Credit Suisse Group reaffirmed an “outperform” rating and issued a $75.00 price target (up previously from $67.00) on shares of DENTSPLY SIRONA in a research note on Thursday, July 13th. UBS AG reaffirmed a “neutral” rating and issued a $59.00 price target (down previously from $62.00) on shares of DENTSPLY SIRONA in a research note on Thursday, August 10th. Finally, Stifel Nicolaus reaffirmed a “buy” rating and issued a $66.00 price target (down previously from $70.00) on shares of DENTSPLY SIRONA in a research note on Thursday, August 10th. Three research analysts have rated the stock with a sell rating, two have given a hold rating and seven have assigned a buy rating to the stock. The stock has an average rating of “Hold” and a consensus price target of $65.80.

WARNING: “Federated Investors Inc. PA Has $356,000 Stake in DENTSPLY SIRONA Inc. (XRAY)” was posted by Daily Political and is owned by of Daily Political. If you are viewing this story on another website, it was copied illegally and republished in violation of United States & international copyright and trademark law. The correct version of this story can be accessed at https://www.dailypolitical.com/2017/09/23/federated-investors-inc-pa-has-356000-stake-in-dentsply-sirona-inc-xray.html.

DENTSPLY SIRONA Inc. (NASDAQ XRAY) opened at 58.53 on Friday. The firm has a 50-day moving average price of $56.98 and a 200-day moving average price of $61.67. DENTSPLY SIRONA Inc. has a 12-month low of $52.54 and a 12-month high of $65.68. The company’s market cap is $13.43 billion.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.65 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.65. DENTSPLY SIRONA had a positive return on equity of 7.24% and a negative net margin of 20.57%. The business had revenue of $992.70 million during the quarter, compared to analysts’ expectations of $1 billion. During the same period in the prior year, the business earned $0.76 EPS. The business’s revenue for the quarter was down 2.9% compared to the same quarter last year. On average, equities research analysts forecast that DENTSPLY SIRONA Inc. will post $2.68 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Friday, October 13th. Shareholders of record on Friday, September 29th will be issued a $0.0875 dividend. This represents a $0.35 annualized dividend and a dividend yield of 0.60%. The ex-dividend date is Thursday, September 28th. DENTSPLY SIRONA’s dividend payout ratio is -10.09%.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.